Bio-Rad

Bio-Rad Q4 Revenues Fall 7 Percent

JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More

360Dx Index Continues Growth in July, Increasing 5 Percent

Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates

Bio-Rad Laboratories Gets CE Mark for SARS-CoV-2, Influenza RT-PCR Assay Kit

FDA Grants EUAs for SARS-CoV-2 Tests, Kits From Exact Sciences, BioGx, Bio-Rad, Everlywell

Bio-Rad Laboratories, Seegene Partner for Infectious Disease MDx Development

Bio-Rad Laboratories Gets CE Mark for SARS-CoV-2 Kit

In Brief This Week: PerkinElmer, Qiagen, BioReference Laboratories, AstraZeneca, and More

Bio-Rad Q1 Revenues Rise 27 Percent, Beat Estimates

Bio-Rad Laboratories, Roche Enter Quality Control Partnership

Bio-Rad Q4 Revenues Jump 27 Percent; Firm Gets FDA EUA for COVID/Flu Combo Test

Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More

In Brief This Week: Illumina, UnitedHealthcare, Thermo Fisher Scientific, and More

Bio-Rad Q3 Revenues Jump 15 Percent

Biodesix Turns to Digital PCR to Maintain Round-The-Clock COVID Testing

Bio-Rad Q2 Revenues Fall 6 Percent on COVID-19 Impact